Neisseriaceae Infections - 25 Studies Found Completed : Safety and Immunogenicity of Novartis Meningococcal Group B Vaccine When Administered Concomitantly With Novartis MenACWY Conjugate Vaccine to Healthy Infants : Infections, Meningococcal : 2014-02-14 : Biological: Meningococcal group B Vaccine, rMenB+OMV NZ Completed : Safety and Immunogenicity of One Dose of Novartis' Meningococcal ACWY-CRM Vaccine and GlaxoSmithKline Biologicals' Meningococcal ACWY-TT Vaccine in Healthy Toddlers : Meningococcal Disease : 2013-11-11 : Biological: MenACWY-CRM MenACW Completed : Phase 2, Observer-Blind, Placebo-Controlled, Randomized, Multi-Center Extension Study to Evaluate the Safety and Immunogenicity of a Booster Dose of a MenABCWY Vaccine Administered 24 Months Following the Primary Series to Adolescents and Young Adults Who Participated in V102_03 (NCT01272180) : Meningococcal Disease : 2013-11-15 : Biological: MenABCWY+OMV Vacci Completed : Testing the Use of Prompts to Increase Adolescent Immunization Rates : Vaccine Preventable Diseases Meningococcal Disease Human P : 2013-11-07 : Other: Point-of-Care Prompt Completed : Safety and Immunogenicity Study of Two Doses of Novartis Meningococcal Serogroup B Recombinant Vaccine in Adolescents Aged 11-17 Years. : Meningococcal Disease : 2013-10-25 : Biological: Meningococcal B Recombinant vaccine rMenB+OMV NZ <<< Previous